Decision Problem Analysis
- Identification of the health problem, epidemiological assessment, review of clinical guidelines, and determination of unmet need and disease burden.
Complete reimbursement dossiers and comprehensive HTA reports
We prepare complete reimbursement dossiers and comprehensive HTA reports for pharmaceuticals and medical devices. Our analyses are based on over 20 years of experience in health economics and Market Access, gained through collaboration with public institutions as well as global pharmaceutical companies.
Thanks to our in-depth knowledge of reimbursement processes and close cooperation with clinical experts and healthcare providers, we deliver reliable, practical, and competitive assessments that effectively support reimbursement decision-making.
Our reports include:
Clinical Analysis
- Evaluation of the efficacy and safety of therapy based on robust scientific evidence, meta-analyses, and systematic literature reviews.
Economic Analysis
- Cost-effectiveness analyses (CEA), cost-utility analyses (CUA), and cost-minimization analyses (CMA), using advanced data modeling tools.
Budget Impact Analysis (BIA)
- Financial forecasts prepared from the perspective of the National Health Fund (NFZ) or NFZ + patient, taking into account different reimbursement scenarios.
Our Experience
Members of our team have prepared hundreds of HTA reports and pharmacoeconomic models for both the Polish and international markets. This experience ensures that our deliverables are not only scientifically sound, but also aligned with the practical needs of the market and healthcare systems.
Why EconMed
- • Experts with unique expertise, combining academic background, work in public institutions, long-term collaboration with the private sector, and practical clinical experience.
- • Collaboration with KOLs and healthcare providers, ensuring access to up-to-date clinical and cost data.
- • Współpraca z KOL’s i świadczeniodawcami, co zapewnia dostęp do aktualnych danych klinicznych i kosztowych.
- • Individualized approach and flexible solutions tailored to business partner needs and regulatory requirements.